University of Montana

ScholarWorks at University of Montana
Graduate Student Theses, Dissertations, &
Professional Papers

Graduate School

2020

A Health Needs Assessment of People Living with HIV in
Montana
Sabrina Singh
University of Montana, Missoula

Follow this and additional works at: https://scholarworks.umt.edu/etd

Let us know how access to this document benefits you.
Recommended Citation
Singh, Sabrina, "A Health Needs Assessment of People Living with HIV in Montana" (2020). Graduate
Student Theses, Dissertations, & Professional Papers. 11626.
https://scholarworks.umt.edu/etd/11626

This Professional Paper is brought to you for free and open access by the Graduate School at ScholarWorks at
University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional
Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please
contact scholarworks@mso.umt.edu.

A Health Needs Assessment of People Living with HIV in Montana

BY
SABRINA SINGH
Bachelor of Arts, Philosophy, Hofstra University
Hempstead, New York
2017
*
PROFESSIONAL PAPER
presented in partial fulfillment of the requirements
for the degree of
Master of Science in Community Health and Prevention Sciences, The University of Montana
Missoula, Montana
May 2020
*
Dr. Annie Sondag, Chair
Health and Human Performance

Dr. Gene Burns
Health and Human Performance

Dr. Joel Iverson
Communication Studies

Table of Contents
Introduction .................................................................................................................................................. 1
History of HIV/AIDS ................................................................................................................................... 1
Epidemiology of HIV in the United States ................................................................................................. 2
Epidemiology of HIV in Montana .............................................................................................................. 4
Treatment as Prevention .......................................................................................................................... 5
Ryan White Care Act ................................................................................................................................. 6
Barriers to Accessing Treatment and Prevention Services ....................................................................... 7
Definition of Terms ....................................................................................................................................... 9
Purpose ......................................................................................................................................................... 9
Research Questions ...................................................................................................................................... 9
Methods ...................................................................................................................................................... 10
Research Design ...................................................................................................................................... 10
Instrumentation ...................................................................................................................................... 10
Sample Selection ..................................................................................................................................... 11
Research Procedures .................................................................................................................................. 12
Data Analysis ........................................................................................................................................... 12
Protection of Human Subjects ................................................................................................................ 12
Results ......................................................................................................................................................... 13
Demographics ......................................................................................................................................... 13
Research Questions Answered ............................................................................................................... 17
Discussion................................................................................................................................................ 25
Portrait of the Participants ..................................................................................................................... 25
Perception of Greatest Needs................................................................................................................. 25
Barriers to Accessing HIV-Related Services............................................................................................. 27
Behaviors Related to Transmission ......................................................................................................... 28
Changes from 2012 to 2018 .................................................................................................................... 28
Delimitations ............................................................................................................................................... 29
Limitations .................................................................................................................................................. 29
Conclusion ................................................................................................................................................... 30
References .................................................................................................................................................. 30
Appendix ..................................................................................................................................................... 35

ii

Introduction
History of HIV/AIDS
Human immunodeficiency virus (HIV) attacks an individual’s immune system by targeting the
CD4 cells (T cells) which aid the immune system in fighting off infections (CDC, 2018c). Without
proper treatment, HIV can destroy the body’s T cells, essentially rendering the body unable to
defend itself against infections, making an individual more likely to contract an opportunistic
infection, and signaling the arrival of AIDS, the last stage of an HIV infection (CDC, 2018c). HIV is
transmitted from a person who is infected through certain bodily fluids including blood, semen,
vaginal fluids and breast milk (CDC, 2018c).
HIV is believed to originate from the chimpanzee form of the immunodeficiency virus,
and it was passed onto humans after the chimpanzee version mutated into HIV (CDC, 2018c).
Researchers have been aware of HIV’s existence in the United States since the mid-1970s. The
Centers for Disease Control and Prevention (CDC) released information on the first cases of
opportunistic infection in young gay men, later shown to be AIDS related, in 1981 (AIDS
Foundation of Chicago, n.d.). By 1992, AIDS became the number one cause of death in
American men between the ages of 25 to 44 (AIDS Foundation of Chicago, n.d.). By 2000,
HIV/AIDS was declared a threat to United States national security (Gellman, 2000). By 2001,
national efforts were undertaken to reduce the rate of HIV transmission in the United States,
ranging from drug manufactures lowering the price of HIV/AIDS drugs to the CDC creating a
new HIV Prevention Strategic Plan to reduce the number of annual HIV infections in the United
States by 50% in five years (HIV.gov, n.d.). The CDC’s high impact approach has been
successful, evident with an estimated 18% decline in annual HIV infections in the United States
from 2008-2014 (CDC, 2017).
As a result of the high number of AIDS related deaths, prevention and treatment of HIV
infection has been well-researched. HIV is a retrovirus, and the specific drugs used to treat a
retrovirus are called antiretrovirals or ARV (HIV.gov, n.d). The first antiretroviral drug approved
by the FDA in 1987 was named azidothymidine (AZT), a type of medicine that helps prevent the
production of DNA and limit the replication of the retrovirus in the blood (Corbett, 2010).
However, because of its toxicity, the drug became controversial, and eventually proved
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ineffective at treating HIV due to HIV’s ability to develop resistance to single-drug treatments
(Corbett, 2010; Food and Drug Administration, 1999).
By 1995, the “AIDS cocktail,” otherwise known as highly active antiretroviral therapy
(HAART), was introduced, and the HIV death rate declined by 47% in 1997 (Food and Drug
Administration, 1999). AIDS cocktails are successful due to their ability to prevent the resistance
to a single drug, but with the rise of HIV strains that are drug-resistant, it is important to
understand the spectrum of treatment and prevention options (World Health Organization,
2017).
Treatments have been effective, and HIV is now characterized as a manageable, chronic
condition. Despite this fact, individuals living with HIV have a lower life expectancy, and are
more susceptible to comorbidities and functional decline than the general United States
population (Chu & Selwyn, 2011; Langebeek et al., 2017; Nasi et al., 2017).
HIV treatment progressed further with the introduction of pre-exposure prophylaxis
(PrEP) and post-exposure prophylaxis (PEP). PrEP is a medicine taken daily by people at very
high risk for HIV to lower their chances of becoming infected. Individuals can reduce their risk
of contracting HIV from sex with an injection drug using partner by over 70% through consistent
PrEP usage (CDC, 2018d). PEP is an antiretroviral medication administered to an individual after
a possible exposure to HIV to prevent that individual from contracting HIV. PEP must be started
within 72 hours of a possible exposure to be effective (CDC, 2018b).

Epidemiology of HIV in the United States
The Centers for Disease Control and Prevention reports that, in the United States, more than
one million people age 13 and older live with HIV (CDC, 2016). Between 2010 and 2014, the
annual number of new HIV diagnoses decreased by 9%, with 39,513 new cases reported in 2015
(CDC, 2016). Some behaviors can lead to a greater chance of HIV transmission (CDC, 2015). It is
important to note that engaging in small risks repeatedly can still lead to a higher overall risk of
contracting HIV (CDC, 2015).
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Table 1 illustrates the demographics of people living with HIV in Montana

Note: Reprinted from 2017- 2021 Montana Integrated HIV Prevention and Care Plan and
the Statewide Coordinated Statement of Need (2016)

3

Epidemiology of HIV in Montana
One important demographic that influences access to care for people infected with HIV is
geographic location. Montana is a rural state in the northwestern United States with a
population of over one million residents (United States Census Bureau, 2017). In 2015, the
Montana Department of Health and Human Services (MTDPHHS) reported 595 individuals living
with HIV in Montana, which included people living out of state at the time of diagnosis who
later became residents. Most cases are from the six most populous state counties - Missoula,
Flathead, Gallatin, Cascade, Yellowstone, and Lewis and Clark. In line with Montana
demographics, most new infections are among non-Hispanic, White males (MTDPHHS, 2017).
Since 2000, 14-32 new cases are reported annually in the state. In 2015, men accounted for 17
new HIV cases, while there was only one new infection among Montana women. This Montana
trend parallels the national pattern with HIV being transmitted primarily among men who have
sex with men, while female infection is largely due to high-risk heterosexual contact (MTDPHSS,
2017).
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Table 2 illustrates the groups most at risk for contracting HIV in the state of Montana

Note: Reprinted from Montana Department of Public Health and Human Services.
(2017). Communicable disease in Montana: 2016 annual report

Treatment as Prevention
Providing treatment and care for people living with HIV in a rural or frontier environment can
provide unique challenges, such as: economic disincentives for private providers; reliance on
generalists; provider shortages; greater use of paraprofessional staff; geographic isolation; and
informal family and community support systems (Nayar et al., 2013; Winbush & Crichlow,
2005). The percentage of people without health insurance is also higher in rural areas. On a
national level, 20% of the 41 million uninsured Americans live in rural areas. In Montana, 70%
5

of the uninsured population lives in a rural area. Oftentimes, decisions must be made about
whether the expense of health insurance is worth the peace of mind that coverage can provide
(Winbush & Crichlow, 2005).
In spite of obstacles to effective care, HIV positive individuals need to manage their HIV
in order to have the best chance at staying healthy while living with the disease (CDC, 2018g).
Additionally, keeping an individual’s viral load under control helps prevent transmission to
others, otherwise known as “treatment as prevention” (CDC, 2018g). Treatment as prevention
is an important component of the HIV care continuum, a system that aides and tracks patients
over time through a comprehensive array of health services (CDC, 2018a). The continuum of
care attempts to reach individuals from a variety of backgrounds who need care, despite the
apparent obstacles to accessing care. The continuum of care is tracked in four areas by the CDC
as illustrated by figure one.
Figure 1. HIV continuum of care as outlined by the CDC

Note: Reprinted from Centers for Disease Control and Prevention. (2018a).
Understanding the HIV care continuum

Ryan White Care Act
On August 18, 1990, the groundbreaking Ryan White Comprehensive AIDS Resources
Emergency (CARE) Act was passed by a wide margin in both houses of Congress (Health
Resources and Services Administration, n.d.) An important component of the HIV continuum of
care, the Ryan White HIV/AIDS program is a wide-ranging system of care that comprises
medical care and vital support services for individuals living with HIV who are underinsured or
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uninsured (Health Resources & Services Administration, 2016). The Ryan White Program is the
third largest source of federal funding to support HIV care in the United States, playing a critical
role in helping to provide care for moderate to low-income individuals (Kaiser Family
Foundation, 2017) The Ryan White HIV/AIDS Program is divided into five parts and is described
below (U.S. Department of Health and Human Services, 2016):

The Ryan White HIV/AIDS Program consisted of 5 sections:
➢ Part A: provides grant funding for medical and support services to population centers
more affected by HIV/AIDS
➢ Part B: provides grants to states and territories to improve the availability, quality, and
organization of HIV/AIDS health care and support services
➢ Part C: provides grant funding to support outpatient HIV early intervention services and
ambulatory care
➢ Part D: provides grant funding to support comprehensive, family-centered care to
women, infants, children and youth living with HIV
➢ Part F: provides grant funding for research, access-to-care, and technical assistance
programs

Barriers to Accessing Treatment and Prevention Services
To more fully comprehend the experience of living with HIV in Montana and the barriers
associated with this disease, it is imperative to learn from and work with individuals living with
HIV. Barriers to treatment and care persist in affecting the quality of life for individuals living
with HIV (Eastwood et al., 2015). Barriers can differ across a variety of demographic factors
such as race, sex, place, ethnicity, and place of residence. Even though HIV is conceptualized as
a chronic, manageable disease, obstacles to care, testing, and treatment remain a vital concern
for individuals of low income, of color, or social or geographic isolation. For health outcomes to
improve for individuals living with HIV, barriers need to be closely analyzed and addressed in a
planned and unified way that is specifically targeted for each HIV subgroup (Pellowski, 2013).
7

Several research studies have demonstrated that individuals living with HIV in rural and
urban areas experience disparate health concerns (Costelloe et al., 2015; Kalichman, Katner,
Banas, & Kalichman, 2017; Pellowski, 2013). For instance, stigmatization aides social distancing,
avoidance, prejudice, discrimination, and self-devaluation (Kalichman et al., 2017).
Furthermore, research shows that individuals living with HIV that experience greater stigma
have poorer mental and physical health outcomes along with decreased medication adherence
(Kalichman et al., 2017). Even though stigma only represents one component of living with HIV,
it highlights the multifaceted relationships that need to be addressed in an integrated manner
to effectively prevent HIV infection.
Other barriers in Montana arise from the rural nature of the state and the economic
status of the residents. Individuals living with HIV in Montana typically are poor, and this status
directly correlates to how these individuals pay for HIV services, (Montana Department of
Public Health and Human Services, 2012). Stigma presents itself in individuals’ fear of lack of
secrecy in small rural communities that decrease the chance for privacy and augment the risk
for discrimination (Montana HIV Prevention Plan, 2012). Another barrier is lack of experienced
HIV/AIDS healthcare providers in Montana (Montana Department of Public Health and Human
Services, 2012).
Finally, inconvenient times of operation and locations of services makes it difficult for
individuals to access care. Operation hours often conflicted with HIV-positive work schedules,
making it difficult for individuals to receive care during the work week (Montana Department of
Public Health and Human Services, 2012). Regarding location, individuals found facilities
inaccessible to them because of the great distances between their place of residence and the
facilities along with their lack of transportation options (Montana Department of Public Health
and Human Services, 2012).
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Definition of Terms
•

ARV: Antiretroviral viral drugs used to treat, not cure, HIV.

•

HIV: Human Immunodeficiency Virus, typically now a manageable disease.

•

IDU: An HIV transmission category relating to injection drug use.

•

MSM: An HIV transmission category relating to men who have sex with men.

•

PEP: Post-exposure prophylaxis can be used after potentially being exposed to HIV; it
must be taken within 72 hours after the potential exposure for maximum efficacy.

•

PLWH: People living with HIV.

•

PrEP: Pre-exposure prophylaxis can be used when people are at very high risk for HIV to
lower their chances of getting infected. It is typically taken daily if someone is
perpetually at a high risk for developing HIV.

Purpose
The purpose of this study was to assess the health-related needs of people in Montana who are
living with HIV. The information from this study was used to describe the behaviors that
contribute to reinfection and/or transmission of the virus to others; barriers to accessing HIV
testing, prevention, and/or treatment services; and, barriers to maintaining treatment and/or
services.
By understanding the experiences of individuals living with HIV in Montana as they
relate to testing, treatment, and navigating the rural healthcare continuum, interventions can
be better enacted to improve health outcomes and quality of life for this demographic.

Research Questions
Below are the guiding research questions for this project:
1. What do individuals living with HIV perceive to be their greatest needs?
o Medical needs, basic living needs, counseling, treatment and support needs
2. In what behaviors do individuals engage that may contribute to transmission of the
virus?
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3. What are the barriers to accessing HIV testing, prevention and/or treatment services?
o Individual, interpersonal, community, and policy level barriers
4. What are the changes between 2012 and 2018?
o Barriers to testing
o Barriers to treatment

Methods
Research Design
This study employed a cross-sectional design. Cross-sectional studies have numerous strengths.
First, this design allowed for the study to be conducted quickly and easily because there were
no long periods of follow-up. Second, the methods were regulated by the researchers, and clear
definitions were utilized, avoiding misconceptions during implementation (Thelle & Laake,
2015). Third, multiple outcomes and exposures were studied at one time (Mann, 2003).
For this study, data was gathered via an electronic and paper survey on a sample of HIVpositive individuals living in Montana at a single point in time for the purpose of identifying the
health-related needs of the study population between June to July of 2018. Consequently, this
paper is an examination of secondary data analysis based off of the data collected during
summer. By directly asking HIV-positive Montanans about their health needs, public health
officials, health care providers, and prevention specialists involved in the planning and
allocation of health resources can be better informed when developing interventions designed
to prevent the spread of HIV and improve the health and well-being of Montanans infected
with HIV.

Instrumentation
The questionnaire for this study, available in a paper format and online1, was developed in
20112 and based on a review of literature including previously developed HIV positive needs
1

The online version of this survey can be found at the link below:
https://umt.co1.qualtrics.com/jfe/form/SV_1RJX5Ym1lIqT6uh
2
The 2011 questionnaire can be found in the following thesis: Epperson, Emily Olive, "A Needs Assessment of
People Living with HIV in Montana" (2012). Graduate Student Theses, Dissertations, & Professional Papers. 276.
Below is the link to the thesis:
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assessment questionnaires used throughout the country. The 2011 questionnaire was designed
to gather information about the demographics of the target population, HIV/AIDS status,
behaviors since becoming HIV positive, assistance and/or prevention and/or treatment service
use, and barriers to assistance and/or prevention and/or treatment services.
Several revisions were made to the existing survey to reflect changes in HIV treatment
and prevention in the past seven years. Specifically, questions were added regarding PrEP and
PEP. The 2018 questionnaire was reviewed by university faculty and by state public health
department staff and edited and revised. Ryan White Case Managers were then asked to
review and comment on the questionnaire, after which further revisions were made. Finally, a
small group of people living with HIV (PLWH) were asked to pilot test the questionnaire prior to
preparing it for distribution to the target population. The final draft of the questionnaire

The questionnaire consisted of 5 sections:
➢ HIV status and treatment
➢ Assistance & Treatment Usage and Needs
➢ Barriers to receiving assistance and treatment
➢ Health behaviors since becoming HIV positive
➢ Demographic information (i.e. race, age, & income level)
consists of five sections which are described below.
The majority of the questions are close-ended with the option for participants to add
their own comments.

Sample Selection
The questionnaire was distributed to people living with HIV 18 years of age or older and live in
Montana. Questionnaire participants were recruited through Ryan White Title II case managers
throughout Montana’s five planning regions who were asked to offer the questionnaire to
clients that were accessing services. Paper copies of the questionnaire were mailed in packets
that included a cover letter, an informed consent form, a $10 incentive, a self-addressed

https://scholarworks.umt.edu/cgi/viewcontent.cgi?article=1295&context=etd
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stamped envelope, as well as a link to the online version of the questionnaire. Case managers
from each region were asked to mail the questionnaires to their clients during the six-week
data collection period. Individuals receiving the packet could choose to take the questionnaire
online or complete the paper copy and mail it directly to the researchers in the enclosed
envelope. Case managers were asked to send follow-up reminders to their Ryan White clients
two weeks and five weeks after the initial release of the questionnaire.

Research Procedures
Data Analysis
The framework used to organize the questionnaire data were the research questions guiding
this project. This framework was preferred with two reasons in mind. First, the questionnaire
was not designed with any theoretical framework in mind, making it impractical to implement a
theory in retrospect. Second, the end goal of this project was to help guide the Montana
Department of Health in meeting the needs of people living with HIV in the state. By organizing
the paper through research questions, it allowed the state to quickly digest the data. Responses
collected from the questionnaire were statistically analyzed using an SPSS computer program.
Questionnaire analysis included descriptive statistics to report the demographics, risk behaviors
associated with HIV transmission, perceived barriers to accessing and maintaining linkage to
prevention and/or treatment services for HIV among people living with HIV in Montana.
Frequencies were reported by actual count and sample sizes. Graphs and charts were used to
illustrate the frequencies when appropriate.

Protection of Human Subjects
The human subject application material and consent forms were completed in accordance with
the University of Montana Institutional Review Board (IRB).
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Results
Demographics
Three hundred and twenty questionnaires were disseminated across the state of Montana by
Ryan White case managers. One hundred and fifty-four were returned, resulting in about a 48%
response rate. The table below shows the age breakdown of the questionnaire participants. The
highest frequency of responses came from individuals in the 55 to 64 age group. Ninety
percent of respondents were over the age of 35.
Table 3. Age of Participants
%

(n)

18 to 25

2.00%

(3)

26 to 34

8.00%

(12)

35 to 44

12.70%

(19)

55 to 64

30.70%

(46)

Over 65

8.70%

(57)

Total

100.00%

(150)

Over 80% of respondents identified at male. Two respondents identified as transgender.
Table 4. Gender Identity of Participants
%

(n)

Male
Female
Transgender (male to female)

81.30%
17.30%
1.30%

(122)
(26)
(2)

Total

100.00%

(150)
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Approximately two-thirds (68%) of the respondents identified as gay or bisexual and over 25%
identified as heterosexual.
Table 5. Sexual Identity of Participants

Heterosexual/Straight
Gay
Bisexual
Other
Total

%

(n)

29.50%
55.00%
12.80%
2.70%
100.00%

(44)
(82)
(19)
(4)
(149)

Employment status varied in the respondents with over half the respondents either being
employed full time or on disability.
Table 6. Employment Status of Participants

Employed full-time
Employed part-time
Not employed
Self employed
Collecting disability
Other (please specify)
Total

%

(n)

29.50%
15.40%
12.80%
4.70%
28.20%
9.40%
100.00%

(44)
(23)
(19)
(7)
(42)
(14)
(149)
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Most of the respondents were living below the poverty line with over 60% making less than
$6,000.
Table 7. Household Income of Participants

Less than 6,000
6,000-10,000
10,001-20,000
20,001-35,000
35,001-50,000
50,001-75,000
100,000+
Total

%

(n)

61.60%
8.90%
10.30%
9.60%
6.20%
2.10%
1.40%
100.00%

(90)
(13)
(15)
(14)
(9)
(3)
(2)
(146)

Over 80% of respondents reported no positive tests for STDs in the past two years.
Table 8. Tested positive for
STDs in the past two years

No
Yes
Total

%

(n)

83.30%
16.70%
100.00%

(125)
(25)
(150)

Over half of the participants did not receive housing assistance.
Table 9. Participants Receiving Housing
Assistance

No
Yes
I’m not sure
Doesn’t apply to me
Total

%

(n)

54.90%
25.40%
1.40%
18.30%
100.00%

(78)
(36)
(2)
(26)
(142)
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Over 90% of the participants did not have any dependent children living with them.
Table 10. Participants Living
with Dependent Children

No
Yes
Total

%

(n)

90.10%
9.90%
100.00%

(136)
(15)
(151)

Nearly one hundred percent of the respondents were taking anti-retroviral drugs at the time of
the questionnaire.
Table 11. Participants Taking AntiRetroviral (ARV) Drugs

No
Yes
Don’t Know
Total

%

(n)

1.30%
97.30%
1.30%
100.00%

(2)
(146)
(2)
(150)
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Research Questions Answered
Research Question #1: What do individuals living with HIV perceive to be their greatest
needs?

Medical care, case management services and financial assistance with medications were the
most frequently cited needs that are currently being met.
Table 12. Services Most Needed and Currently Used
%

(n)

Medical care (doctor, nurse, clinic, etc.)

84.80%

(128)

Case management services

75.50%

(108)

Financial assistance with medications

73.30%

(110)

Help paying for health insurance

58.70%

(88)

Dental care

58.50%

(86)

Emergency financial assistance (utilities, food/groceries, meds,
transportation, housing)

45.60%

(68)

Mental health services

41.70%

(60)

Referral services (i.e. non-medical case manage, rehab, or
psychosocial services)

39.00%

(57)

Enrollment into insurance

35.40%

(51)

Treatment adherence support

30.60%

(45)
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None of the services listed were reported as an unmet need by more than 15% of the
respondents.
Table 13. Services Most Needed and Cannot Get
%

(n)

Dental Care

15.00%

(22)

Buddy/companion volunteer support

12.10%

(17)

Emergency financial assistance (utilities, food/groceries, meds,
transportation, housing)

10.70%

(16)

Legal services (excludes criminal defense and class-action
lawsuits)

9.80%

(14)
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Research Question #2: What are the barriers to accessing HIV testing, prevention, and/or
treatment services?
Overall the most significant barriers for testing were associated with interpersonal and logistical
factors.
Table 14. Barriers to HIV Testing
%

(n)

I thought I was at low or no risk 15.80%

(29)

Too scared to find out the results

9.24%

(17)

I was in a monogamous relationship

6.50%

(12)

I didn’t know about HIV

6.00%

(11)

I was too scared to get the test done

6.00%

(11)

I was afraid of being discriminated against

5.43%

(10)

I was afraid of losing my job if HIV+

4.90%

(9)
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The main barriers to obtaining and using HIV services were related to both mental health and
logistics in terms of transportation and affordability.
Table 15. Barriers to Obtaining and Using HIV Services
%

(n)

My state of mind or mental ability to deal with treatment

26.90%

(39)

Burn-out from dealing with talking about HIV

24.80%

(36)

Not having transportation

22.20%

(32)

Not having insurance coverage

20.00%

(29)

My concern other people may see me when I go to get care

19.30%

(28)

Not knowing what service or treatment is available to me/lack of
services

19.30%

(28)

The cost of attendance or treatment.

17.80%

(26)

Not knowing who to ask for help.

17.40%

(25)

The location of the organization providing services.

16.60%

(24)

Lack of experience or expertise of the person providing the services to
me.

16.10%

(23)

Overwhelmingly, respondents who started HIV treatment continued to adhere to their
treatment plan.
Table 16. Participants who
Decided to Discontinue
Treatment Plan
%

(n)

No

92.90%

(118)

Yes

7.10%

(9)

Total

100.00%

(127)
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Research Question #3: In what behaviors do individuals engage that may contribute to
transmission of the virus?
Over two-thirds of the respondents knew about PrEP.
Table 17. Participants who Knew about PrEP

No
Yes
Unsure
Total

%

(n)

23.60%
67.60%
8.80%
100.00%

(35)
(100)
(13)
(148)

Over half the respondents knew about PEP.
Table 18. Participants who Knew
about PEP
No
Yes
Unsure
Total

%

(n)

33.80%
55.40%
10.80%
100.00%

(50)
(82)
(16)
(148)

Overwhelmingly, participants said that viral suppression was very important to them.
Table 19. Importance of Viral
Suppression
Somewhat important
Very important
Total

%

(n)

5.40%
94.60%
100.00%

(8)
(139)
(147)
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Approximately two-thirds of the participants expressed some level of comfort in sharing their
HIV+ status with their sexual partner.
Table 20. Comfort in Disclosing HIV+ Status to Sexual Partner

Very comfortable
Somewhat comfortable
Somewhat uncomfortable
Very uncomfortable
Total

%

(n)

45.00%
22.10%
16.40%
16.40%
100.00%

(63)
(31)
(23)
(23)
(140)

More than half of the respondents reported using a condom when they engaged in sexual
activity since becoming HIV positive.
Table 21. Sexual Activity since becoming HIV+

Stopped having sexual relations (I am abstinent)
Never use condoms
Sometimes use condoms
Always use condoms
Total

%

(n)

29.20%
13.90%
30.60%
26.40%
100.00%

(42)
(20)
(44)
(38)
(144)

Overwhelmingly, participants had not injected any substances within the past year.
Table 22. Injection of Substances
within the Past Year

No
Yes
Total

%

(n)

91.30%
8.70%
100.00%

(136)
(13)
(149)
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Research Question #4: What were the changes in barriers from 2012 to 2018?

While direct comparisons cannot be made between participants in the 2012 versus 2018
assessment, it is interesting to note that the percent of individuals reporting they encountered
the barriers listed in the table declined substantially in all areas except for transportation.
Table 23. Barriers to Obtaining and Using HIV Services from 2012-2018

2018
%

(n)

2012
%

(n)

My state of mind or mental ability to deal with treatment 26.90% (39) 35.00% (57)
Burn-out from dealing with talking about HIV 24.80% (36) 44.00% (71)
Not having transportation 22.20% (32) 23.00% (37)
Not having insurance coverage 20.00% (29) 58.00% (93)
My concern other people may see me when I go to get care 19.30% (28) 42.00% (70)
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Again, direct comparisons between participants in each assessment cannot be made. It is
interesting to note, however, the percent of individuals reporting they encountered the barriers
listed below declined substantially in all areas.
Table 24. Barriers to Testing from 2012-2018
2018
%

(n)

2012
%

(n)

I thought I was at low or no risk 15.80% (29) 32.00% (16)
Too scared to find out the results

9.24% (17) 24.00% (12)

I was in a monogamous relationship

6.50% (12) 16.00%

(8)

I didn’t know about HIV

6.00% (11) 10.00%

(5)

I was too scared to get the test done

6.00% (11) 16.00%

(8)

I was afraid of being discriminated against
I was afraid of losing my job if HIV+

5.43% (10) 20.00% (10)
4.90%

(9)

8.00%

(4)
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Discussion
Portrait of the Participants
While the individuals living with HIV in Montana come from a variety of backgrounds, it is
possible to distinguish key characteristics that comprise the respondents. The 154 respondents
were overwhelmingly male, composing over 80% of the participants. Just over two-thirds
identified as gay men or as bisexual (68%), showing consistency with national trends.
Additionally, most of the participants self-identified as white (87.18%), with Native Americans
being the second largest represented racial group (7.69%). This data on race and ethnicity
closely matches Montana census data (Census, 2017). Many respondents were middle aged,
with over half the participants being over 45 years old. Overwhelmingly, the respondents did
not have dependent children living with them which may speak to the fact that over two-thirds of
the respondents were gay or bisexual men. Over half the respondents were employed full-time.

Over 25% were collecting disability benefits.
Following is a discussion of data collected quantitatively through a statewide
questionnaire. The researchers examined perception of greatest needs, barriers to accessing
HIV services, behaviors in which individuals engage that may contribute to transmission of the
virus, and changes in the perceptions of HIV services from 2012 to 2018.

Perception of Greatest Needs
This research question was broken down into services most needed and used along with
services that were needed, but not accessible. The results were mostly positive, meaning that
goal four of the HIV/AIDS Strategy (2015): “achieving a more coordinated national response to
the HIV epidemic,” is being met within the state of Montana. The most needed and used
service for individuals living with HIV in Montana is medical care with 84% citing it as a used
service. Case management was also a critical service with three-quarters of respondents
indicating they both needed and used it. These statistics make sense because most individuals
living with the illness are living long and healthy lives while managing their chronic conditions,
assuming they receive treatment (Mahon, 2017). Furthermore, the HIV/AIDS Strategy (2015)
has been focusing on how to increase widespread linkage to care, regardless of area of
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residence. Case managers play a critical role in linking their clients to care, meaning that
medical care is a highly used service now and in the coming years (National HIV/AIDS Strategy,
2015).
However, there is always more to do, and participants indicated there are currently
services they need and cannot access. The top service needed was dental care with 15% of
respondents indicating they were unable to access this service. The need for this service makes
sense when one takes into account that when individuals are infected with HIV, they are more
likely to develop tooth loss and pain in the mouth (Evans, 2009). Considering that Montana is a
rural state, healthcare specialists such as dentists may not be easily accessible due to lack of
transportation or distance between the individual and the provider (Nayar et al., 2013;
Winbush & Crichlow, 2005).
The second most needed service was buddy/companion volunteer support. Older
individuals living with HIV have high rates of loneliness which can lead to a variety of mental
health issues (Greene, Hessol, Perissinotto, & Zepf, 2017; Moskowitz & Trykowski, 2017).
Buddy programs can reduce these high rates of loneliness in HIV-positive individuals (Burrage &
Demi, 2003). For instance, the Gay Men’s Health Crisis Buddy Program has reported a reduction
in social isolation for the clients enrolled in the program (Moskowitz & Trykowski, 2017).
Participants cited helpful aspects of the program such as “the fact that they didn't know each
other beforehand, that they have a commitment to talk once a week, that they're there
specifically to talk and not as a date” (Moskowitz & Trykowski, 2017). While the program was
located in an urban area, a buddy program of a similar nature could do well in Montana.
The third most needed service was emergency financial assistance. The request for
emergency funds makes sense when demographic information is considered. Most of the
participants were gay or bisexual men, and LGBTQ individuals are more likely to live below the
poverty line than heterosexual individuals (Fredriksen-Goldsen, Kim, Barkan, Muraco, Hoy-Ellis,
2013). Consequently, these individuals are less likely to have enough money to cover their living
expenses, and they may need access to funds if an unexpected situation arises.
The fourth most needed service was legal services. Legal service providers can aid in
tackling barriers to accessing and maintaining care among individuals living with HIV, making
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these services important in reducing disparities for the population (Miyashita & Hasenbush,
2016). For this study, “legal services” was not specifically defined, meaning that participants
may need legal services in a variety of areas such as housing, employment, and discrimination
issues. Consequently, it is difficult to extrapolate specific reasons why individuals living with HIV
are seeking legal services.
It is, however, important to note that none of the services were reported as inaccessible
by more than fifteen percent of participants. It appears that Montana is doing a good job of
providing services to this group of individuals living with HIV.

Barriers to Accessing HIV-Related Services
The second section of the questionnaire focused on barriers in relation to testing and
prevention, and treatment. For testing, the number one barrier was the perception of low risk.
However, it is important to note that many of the participants are in their late forties to late
sixties, meaning they originally got tested in the 1980s and 1990s. During this time period,
there was a significant amount of stigma surrounding the illness and a lack of knowledge
concerning potential risks for contracting HIV. Consequently, these two factors may have
affected the perceptions of barriers to testing.
In terms of prevention and treatment, the overwhelming majority said that once they
started treatment, they had not discontinued. This lack of discontinuation from treatment may
be attributed to greater accessibility of medication and coordination efforts with the state to
help care for individuals living with HIV (CDC, 2018a). However, individuals still perceived some
barriers with 27% attributing their mental mindset as an inhibitor to seeking out treatment and
prevention. This barrier makes sense in light of previous research. Specifically, stigmatization
aides in social distancing and avoidance (Kalichman et al., 2017). In essence, individuals take on
the stigma that they perceived is attributed to them by society, it affects their mindset, and
they distance themselves, leading to poorer health outcomes. Consequently, the biggest
barriers were individual-based.
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Behaviors Related to Transmission
Individuals living with HIV are engaging in generally positive behaviors that are reducing overall
transmission. For instance, 67% knew about PrEP. That statistic is consistent with the national
trend. Specifically, the number of adults prescribed PrEP increased by more than 300% from
7,972 in 2014 to 33,273 in 2015 (Wolitski, 2017). Furthermore, the participants of this
questionnaire were contacted through Ryan White case managers, meaning they may have
known about PrEP because of the organization’s support for the treatment (Cheever, 2016).
In terms of viral suppression, the questionnaire data shows that one hundred percent of
participants thought that viral suppression was either “somewhat important” or “very
important,” meaning that HIV-positive individuals are aware of how their illness affects both
their own quality of life and others. This overwhelming statistic can be attributed to aggressive
efforts by governmental and private organizations to spread awareness about the illness
(National HIV/AIDS Strategy, 2015).

Changes from 2012 to 2018
Barriers to testing as well as obtaining and using services were greatly reduced from 2012 to
2018. In terms of barriers to testing, the reduction can be partially attributed to the attempts at
normalizing testing. Currently, the Centers for Disease Control recommends that individuals
between the ages of 13 to 64 get tested for HIV at least once as a component of their health
care, and individuals who possess risk factors ought to get tested yearly (CDC, 2018e).
In terms of barriers to accessing treatment, the top five concerns shifted. In 2012, the
number one concern was lack of insurance coverage across participants in all five regions of
Montana. In 2018, the number one barrier was the individual’s state of mind or mental ability
to handle receiving treatment. This change in perception of barriers can be attributed to the
implementation of the Affordable Care Act which has helped to increase coverage for
individuals living with HIV without bankrupting these individuals (AIDS.gov, 2015).
The only barrier that has not greatly decreased is lack of transportation. Transportation
barriers lead to missed appointments, delayed care, and missed medication use because
individuals cannot obtain new prescriptions (Syed, Gerber, & Sharp, 2014). Ultimately,
transportation issues can result in poor management of chronic illnesses and poor health
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outcomes (Syed, Gerber, & Sharp, 2014). Lack of transportation appears to be a long-term
problem for individuals living with HIV in Montana. In part, this issue is perpetuated by
Montana’s rural nature and the great distances individuals need to travel in order to access
health care services. This barrier can potentially be reduced by lowering transportation costs
through infrastructure improvements or increasing broadband access in rural areas to improve
access to telehealth services (Watson, 2016).
Currently, Montana has the third lowest rate of HIV infection in the United States (CDC,
2018f). Public health officials continuing efforts to prevent transmission of the virus will ensure
that this trend continues.

Delimitations
A number of delimitations exist in this assessment. First, the study was delimited to individuals
living with HIV, who are age 18 or older, who reside in Montana, and have accessed a Ryan
White Title II case manager. Second, the data was collected through an online and paper
questionnaire from individuals who are living with HIV in Montana. Third, the data collected
from participants was restricted to self-reports. Fourth, participants in the study were
volunteers who may discontinue involvement at any time, at their own discretion.

Limitations
A variety of limitations were present in this needs assessment. Only opinions of 154 of the 595
individuals known to be HIV positive in Montana are reported in the data. Currently, 88% of the
questionnaire participants have a case manager, and 96% of the participants stated they were
currently receiving treatment. Participants were not randomly selected, and as a result, these
individuals highlight a limited view of the types of people living with HIV in Montana.
Consequently, it is assumed that individuals who did not participate in the needs
assessment depict a wide range of individuals living with HIV in Montana. These individuals may
have access to the services they need to live a healthy life while other individuals may be
isolated or impoverished to the point that they may not have knowledge or access to necessary
HIV-related services.
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In addition, most of the questionnaire participants have been living with HIV for more
than 10 years. Since the nature of HIV prevention and treatment is constantly changing, the
needs of recently diagnosed individuals can differ substantially from individuals who were
diagnosed more than 10 years ago.

Conclusion
Individuals diagnosed with HIV can live longer lives due to the creation of effective treatments.
However, a longer life expectancy does not necessarily mean a better quality of life. This needs
assessment was an effort to examine barriers to treatment and care for individuals living with
HIV in Montana. For this research project, 154 HIV-positive individuals completed a
questionnaire. A majority of the participants had few economic resources, limited employment
opportunities, and experienced health complications as a result of their diagnosis. Despite
these inequities, results of this assessment reveal that many of the barriers to getting an HIV
test and to obtaining needed services were greatly reduced from the 2012 assessment. In part,
this can be attributed to the fact that 88% of respondents were connected to a case manager,
allowing them the opportunity to receive help. Nevertheless, there is still a great deal that can
be done to improve the quality of life of people living with HIV. By increasing awareness about
HIV prevention and treatment along with addressing the social and economic inequities that
often accompany a diagnosis of HIV infection, people living with HIV can live longer, healthier
lives, thereby making the National HIV/AIDS Strategy vision a reality.
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Montana
2018 Health Needs
Questionnaire

?
Let your needs be known!
Influence funding decisions that affect you!
•

The purpose of this survey is to clarify the health care needs of
people living with HIV in Montana.

•

Your participation in this study will help plan programs for you and
others living with HIV.

• Your participation is VOLUNTARY.
• All responses are strictly ANONYMOUS.
• Please DO NOT put your name on this survey.

Please return this survey to your case manager or
mail in the self-addressed stamped envelope as
soon as possible.

THANK YOU VERY MUCH!
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PART 1:
TELL US ABOUT YOUR HEALTH

TELL US ABOUT YOUR HIV/AIDS STATUS
(Your answers are strictly ANONYMOUS!)
TELL US ABOUT YOUR HIV/AIDS STATUS
1. In general, how would you rate your overall health?
 Very good
 Good
 Fair
2. How do you believe you became infected with
HIV?
 Sex with a man
 Sex with a woman
 Sex with an injection drug user
 Injecting drugs




Poor
Very poor





Blood transfusion
Don’t know
Other (please specify): ____________

3. How many years ago did you learn you were HIV+? ______

4. When you found out you were HIV+, were you also diagnosed with AIDS?
 No
 Can’t remember
 Yes
5. If you put off getting tested, why didn’t you test sooner?
(check all that apply)
 I thought I was at low or no risk





I didn’t know about HIV








There is no cure, why bother



Testing hours were inconvenient

I didn’t care if I was HIV+ or not
I was afraid of being discriminated against if I
was HIV+
I was afraid of losing my partner
Too long to wait for results
HIV test was too expensive
Insurance reasons
I didn’t trust the health department/testing
location















I wasn’t sure where to get tested
Testing location was inconvenient
I was afraid of losing my job if I was HIV+
I always practiced safe sex
I was afraid of being alienated from my family
I was in a monogamous relationship
I was too scared to get the test done
I was afraid of needles
Too scared to find out the results of the test
I practiced only oral sex
I thought it was a gay disease
I usually practiced safe sex
Other ____________________________________

6. How long after learning you were HIV positive did you seek treatment?
 I have not yet sought treatment
 Less than one week
 1 week to 3 months
 3 to 6 months
 6 months to 1 year
 More than 1 year
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7. Do you currently take anti-retroviral (ARV) drugs?
 No
 Yes
 Don’t Know
8. Do you know your current CD4 count and/or your viral load?
 No
 Yes
9. Have you had a CD4 count or viral load in the last 12 months?
 No
 Yes
10. Have you ever had a case manager?





I have one now
I no longer have one
I never had one

11. If you are receiving treatment, how did you get
linked to treatment or related services?

If you answered “no longer” or “never,” why not? (check all
that apply)
 I don’t need services
 I can get services myself
 I didn’t know one was available
 I live too far away
 I’m worried people will find out I have HIV or AIDS
 I don’t know how a case manager could help me
 A different service provider helped me get services
 They don’t speak my language
 They don’t understand my culture
 Use alternative therapy/standard medicine too harsh
 Confidentiality
 Other ____________________________________









I have never been linked to treatment or services for
HIV
My personal doctor/health care provider connected
me with treatment and services
I have an HIV positive friend/acquaintance who
helped me find services
The person who did my HIV test referred me to a
Ryan White case manager
The person who did my HIV test linked me to
treatment services
I looked on the internet to find out where to get
treatment and services
Other_____________________________________________
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PART 2:
WHAT ASSISTANCE & TREATMENT ARE YOU USING?
WHAT CAN’T YOU GET?

STEP 1:
On the following pages, you’ll find a list of assistance and treatment opportunities. For
each opportunity listed, put a
in one of the three boxes.
STEP 2:
If you check the box “need can’t get,” tell us the reason you can’t get this assistance or
treatment.
If you don’t tell us what’s wrong, we can’t fix it!
Some of the reasons other people have mentioned include:
•
•
•
•
•
•

Can’t afford it
Live too far away
Don’t feel welcome at the agency
Not sick enough
Don’t know where to get it
The service doesn’t meet my needs

Please feel free to mention other reasons.
EXAMPLE:
Assistance/
Treatment

Need
and
use

Dental care
Support groups

Don’t
need

Need,
can’t
get

✓

Why I can’t get it…
(Please let us know so we can
help!)

Can’t afford it

✓
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MEDICAL AND RELATED ASSISTANCE & TREATMENTS
Assistance/
Treatment

Need
and
use

Don’t
need

Need,
can’t
get

Why I can’t get it…
(Please let us know so we can help!)

Treatment adherence
support (help taking your
HIV meds correctly)
Physical or Occupational
Therapy
Nutritional counseling
Medical Equipment
(wheelchair, etc.)
Mental health services
Financial assistance with
medications
Medical care (doctor,
nurse, clinic, etc.)
Help paying for Health
Insurance
Dental Care
Referral for substance
abuse treatment
counseling
Other (please specify):
_________________________
_________________________
_________________________

If you are currently using naturopathy, herbal medicine,
Acupuncture or other non-Western therapies, do you consider
this to be your primary form of medical care?

□ NO

□ YES

BASIC
NEEDS
TREATMENTS
If “YES”,
please AND
specifyASSISTANCE
which therapies&
are
most important to you: _________________________________________
___________________________________________________________________________________________________________
Assistance/
Need
Don’t
Need,
Why I can’t get it…
_______
Treatment
and
need
can’t
(Please let us know so we can help!)

use

get

Emergency Financial Assistance
(utilities, food/groceries, medication,
transportation, housing)
Home delivered meals/Food bank
Home Health Care
Medical Transportation (assistance
getting to/from HIV medical
appointments)
Practical support (help with budgeting,
cooking, cleaning, laundry, chores,
moving, pets, etc.)
Other (please specify):
______________________________________
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COUNSELING, TREATMENT AND SUPPORT ASSISTANCE & TREATMENTS
Service

Need
ands
use

Don’t
need

Need,
Can’t
get

Why I can’t get it…
(Please let us know so we can help!)

Case management
services
Referral services (i.e. nonmedical case
management,
rehabilitation or
psychosocial support
services)
Child care
Legal services (excludes
criminal defense and
class-action suits)
Enrollment into insurance
Buddy/ Companion
volunteer support
Support groups/ peer
counseling
Spiritual support
Other (please specify):
________________________

Are there other types of help that we have not mentioned that you would like
to have access to, or are currently using?
_________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
____________________________________________________________________
•

•

Are there types of help listed above and on the previous page that you do
not need now, but think that you may need in the future? If so, please
specify them in the space below.

____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________________________________
____________________________________________________________
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PART 3:
BARRIERS TO RECEIVING ASSISTANCE & TREATMENT
Did you obtain medical care for HIV and/or start anti-retroviral therapies and then decide to discontinue
your care or your medications?
 Yes
 No
 I have never received medical care

Below is a list of possible problems that may arise when trying to obtain or when using
HIV and AIDS services. Mark an X on the line beside each item to say if it has been a
problem for you or not.
Barrier

Not a
Barrier

1. Not knowing what service or treatment is available to me/ lack of services.
2. The location of the organization providing services.
3. My physical health.
4. The quality of assistance or treatment.
5. Not knowing what medical assistance or treatment I need to treat my HIV
or AIDS infection.
6. My state of mind or mental ability to deal with the treatment (e.g. anxiety,
depression or other mental illness).
7. Having a substance abuse problem.
8. Not having transportation.
9. Not knowing who to ask for help.
10. My concern that other people may see me when I go to get care or learn
about my HIV infection (lack of confidentiality/stigma).
11. Discrimination I experienced by the persons or organization providing the
services.
12. Lack of experience or expertise of the person providing services to me.
13. The hours when services were offered were unreliable or inconsistent.
14. The amount of time I had to wait to get an appointment to see someone.
15. The cost of assistance or treatment.
16. Not having insurance coverage.
17. Burnout from dealing with/ talking about HIV.
18. Other (please specify):

Of the barriers listed above, which two do you believe are the biggest barriers you have faced
when trying to get HIV related services?

a) _________________________________________________________________________________
b) _________________________________________________________________________________
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PART 4:
PART 4:
TELL US ABOUT YOUR BEHAVIORS SINCE BECOMING
HIV POSITIVE
(This is ANONOMOUS and you don’t have to answer any questions that make you uncomfortable.)
12. Which best describes your sexual activity since becoming HIV positive?
 Stopped having sexual relations
(I am abstinent)
 Never use condoms
If you use condoms “sometimes,” in what
 Sometimes use condoms
situations do you NOT use them?
 Always use condoms
 With my regular partner who is HIV+
 When my viral load is low or undetectable

 With any sex partner who is HIV+
 When my sex partner refuses to use condoms
 When I feel uncomfortable bringing up condoms
 Other _________________________________________
13. Do you know there is a pill that prevents HIV (PrEP)?
 No
 Yes
 Unsure

14. Do you know there is a pill that can be used after a
possible exposure to HIV transmission to prevent
infection (PEP)?
 No
 Yes
 Unsure
15. How important is viral suppression to you?
 not important
 somewhat important
 very important
16. If you have an undetectable viral load, do you
think you still need to disclose your HIV status to
potential sex partners?
 No
 Yes




Sometimes
Not sexually active

17. How comfortable are you disclosing your status to
your sexual partner.
 Very Comfortable
 Somewhat Comfortable
 Somewhat Uncomfortable
 Very Uncomfortable
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17. Have you tested positive for sexually transmitted diseases in the last two years?
 No
 Yes
If “yes”, which did you test positive for? (check
all that apply)
 Syphilis






Genital warts
Gonorrhea
Herpes
Chlamydia

 Other (specify):_____________________
18. Do you have any other medical conditions besides HIV/AIDS?
 No
 Yes
If “yes”, what illnesses do you have?
(check all that apply)
 Hepatitis C/ Hepatitis B
 Diabetes
 Alcoholism
 Drug dependency
 Heart disease
 Mental illness
 Opportunistic Infection(s)
 Other (please specify): _____________________
19. Have you used substances in the past year?
 No
 Yes

20. Have you injected any substances in the past
year?
 No
 Yes

If “yes”, check all substances you have used:
 Alcohol
 Marijuana
 Crack
 Cocaine
 Heroin
 Meth/Crystal
 Downers
 Other (please specify): ________________

If “yes”, have you shared needles while injecting drugs in
the past year?
 No
 Yes

21. Do you believe that your substance use is a problem?
 No
 Yes
 Not sure
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22. Do you have emotional concerns which have caused a problem for you in the last 6 months?
 No
 Yes
If “yes”, what are your emotional concerns? (check
all that apply)
 Stress









Depression
Guilt
Suicidal tendencies
Anger/resentment
Anxiety/fear (concern about the future)
Loneliness (isolating yourself)
Other (please specify): ___________________

23. Are you receiving any treatment for emotional or stress related problems (depression)?
 No
 Yes
If “yes”, what treatment are you using? (check all
that apply)
 Prescription medicine
 Alternative therapies

 Counseling
 Medical Marijuana
 Other (please specify) _______________________

24. Has becoming HIV+ caused problems in your close relationships?
 No
 Yes
If “yes”, what problems has it caused? (check all that
apply)
 Stress or isolation in relationships with family
 Difficulties in relationship with spouse/partner

 Involvement with people who want to be
Infected (POZ chasers)

 Difficulties in relationship(s) with children
 Other (please specify):_____________________

25. What type of counseling do you prefer? (check all that apply)





Individual (just a counselor and me)
Group counseling (with other HIV+ people)
Peer counseling (by other HIV+ people)

 Religious or pastoral counseling
 I am not interested in counseling
 Other (please specify):______________________
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PART 5:
TELL US ABOUT YOURSELF
(Remember, your answers are strictly ANONYMOUS)

26. What is your gender identity?
 Female
 Male

27. What is your race/ethnicity? (check all
that apply)
 Native American/AK Native
 Asian/Pacific Islander
 African American





Transgender (male to female)
Transgender (female to male)
Other _____________________________





White (non-Hispanic)
Hispanic
Other (please specify): _________________

28. What is your age?
 18 to 25
 26 to 34
 35 to 44





29. How do you identify?
 Heterosexual/Straight
 Gay
 Lesbian

45 to 54
55 to 64
Over 65




Bisexual
Other: ____________________________

30. What is your current employment status?
 Employed full-time
 Employed part-time
 Not employed





Self-employed
On disability
Other (please specify): ______________

31. What is your monthly household income?
 Less than 6,000
 6,000-10,000
 10,001-20,000
 20,001-35,000






35,001-50,000
50,001-75,000
75,001-100,000
100,000+






Jail or prison
Drug/alcohol treatment center
Living in public housing
Other: _________

32. Where are you living now? (check all
that apply)
 Your own house or apartment
 In a friend or relative’s
house/apartment
 Hospice or nursing facility
 Live on the streets or in a shelter
 Pre-release center
33. If you are living in your own house or
apartment, are you receiving housing
assistance?






No
Yes
I'm not sure
Does not apply to me

46

34. Do you have any dependent children
living with you?
 No
 Yes
35. Do you have health insurance or other
assistance?
 No
 Yes

If “yes”, how many dependent children are living with you? _____

If “yes”, what kind of insurance or other assistance do you have?
 Medicaid
 Medicare
 Private insurance
 ACA (marketplace) insurance
 Employer based insurance
 Ryan White HIV/AIDS Program Assistance (ADAP)
 Veterans benefits
 Indian Health Service or Tribal Health
 Other: __________________________________

1. What kinds of things may have helped you avoid infection with HIV?(check all that
apply)










Being more aware that infection with HIV was a possibility for me
Being more knowledgeable about how HIV is transmitted
Knowing where to find clean needles or clean works
Getting treatment for depression or other emotional problems
Getting treatment for a substance abuse problem
Knowing how to bring up the subject of protection with a sex partner
Knowing the importance of talking to a sex partner about his or her HIV status
Other. Please describe any of the issues checked above in more detail or describe
other things that may have been helpful to you.

________________________________________________________________________
________________________________________________________________________
2. What is the best way that the public health department and the Ryan White Care

Program can get information about prevention, treatment, and services to you?
(Check all you think would be helpful)













Billboards
Health care provider – doctors, nurses, etc.
Internet / health department website
Facebook, Instagram or Twitter (other) ____________________
Community educational events like health fairs
Movies/television clips/television commercials/magazines
Announcements on the radio (which stations are best?) _______________
Advertisements or articles in newspapers
Case managers
Peers and friends
Other ways that we can get information to you? ______________________________
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3. What is the single most important change you would suggest to improve the

quality of life for individuals or families living with HIV?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

For contact information for a HIV medical case manager in your area,
call 406-444-3565 or visit
http://dphhs.mt.gov/publichealth/hivstd/treatmentprogram

THANK YOU!
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